Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somnus Study: Transition to Lemborexant in Japanese Patients With Insomnia
jRCTs071200093Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd. Primary endpoint: Proportion of patients with successful lemborexant treatment at end of first treatment phase. Started Mar 2021; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCTs071200093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200093.